Katalin Kariko

Quick Facts

Full Name	Katalin Kariko
Occupation	Biochemist
Date Of Birth	Jan 17, 1955(1955-01-17)
Age	69
Birthplace	Szolnok
Country	Hungary
Horoscope	Capricorn

Katalin Kariko Biography

Katalin Kariko is one of the most popular and richest Biochemist who was born on January 17, 1955 in Szolnok, Hungary. Katalin Kariko (born 17 January 1955 in Szolnok, Hungary) is a Hungarian biochemist who is specialized in RNA-mediated processes. Her work has focused on the development of mRNA that is transscribed in vitro to treat diseases using protein. She is currently an Executive Vice President of BioNTech Research and Development of RNA Pharmaceuticals.

Kariko’s research and work Kariko has been instrumental in BioNTech’s endeavor to create immune cells that make vaccine antigens. Kariko’s work has revealed the capability to enhance the antiviral response of the mRNA of its cancer vaccinations additional boost in the fight against cancerous tumors.

in 2012 Kariko as well as Drew Weissman who was an immunologist from the University of Pennsylvania, received patents to use a number of modified nucleosides in order to decrease the immune response of the antiviral to mRNA. They also created a small business. Shortly after, UPenn sold the intellectual patent to Gary Dahl, the head of a lab supply business which later changed its name to Cellscript. After a few weeks, Flagship Pioneering, the venture capital firm that was and continues to be a major shareholder of Moderna approached her to discuss license the invention. The only thing Kariko stated was “we don’t have it.” In the early months of the year Kariko was informed of Moderna’s $240 million agreement with AstraZeneca to create an VEGF transcript. Kariko was aware that she would not have the opportunity to use her expertise in mRNA research at UPenn and stepped into her new position as Senior Vice President of BioNTech the RNA pharmaceuticals.

Katalin Kariko Net Worth

Katalin Kariko is one of the richest Biochemist from Hungary. According to our analysis, Wikipedia, Forbes & Business Insider, Katalin Kariko 's net worth $5 Million. (Last Update: December 11, 2023)

In 1990, as an Associate Faculty member of the University of Pennsylvania, Kariko presented her first grant application that sought the development of mRNA-based gene therapy. Ever since the beginning, mRNA-based therapies have been the main research area of Kariko’s. Kariko worked for over two decades as professor of the University of Pennsylvania Medical School.

Kariko’s research involves scientific investigation of RNA-mediated immune activation that results in the discovery of nucleosides that reduce the immunegenicity of RNA. This could increase the therapeutic possibilities of the mRNA. Kariko holds patents within the United States for application of non-immunogenic nucleoside-modified RNA. She co-founded and was the CEO of RNARx from 2006 to 2013.. Katalin Kariko’s mother is two-time Olympic gold medalist Susan Francia.

Height, Weight & Body Measurements

Katalin Kariko height Not available right now. Katalin weight Not Known & body measurements will update soon.

Who is Katalin Kariko Dating?

According to our records, Katalin Kariko married to Béla Francia. As of December 1, 2023, Katalin Kariko’s is not dating anyone.

Relationships Record : We have no records of past relationships for Katalin Kariko. You may help us to build the dating records for Katalin Kariko!

Facts & Trivia

Katalin Ranked on the list of most popular Biochemist. Also ranked in the elit list of famous people born in Hungary. Katalin Kariko celebrates birthday on January 17 of every year.